MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Heatmap
  • Русский
  • 中文
  • Español
  • Português
  • 日本語
  • Deutsch
  • 한국어
  • Français
  • Italiano
  • Türkçe
Vaxcyte, Inc. Common Stock

PCVX

#982
Vaxcyte, Inc. Common Stock
60.5250 USD
-3.56%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
60.1900
60.9150
Year Range
39.8700
64.7850
Daily Change
-3.56%
Monthly Change
+9.87%
6 month change
+43.09%
Year Change
+43.09%
Previous Close
62.7600
Open
60.8400
Bid
Ask
Low
60.1900
High
60.9150
Volume
510
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. PCVX
Open full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 8.7108 B
  • Employee 507
  • Founded 2013
  • CEO N/A
  • Website www.vaxcyte.com
  • Headquarter Delaware, United States
  • FIGI BBG009PHHPL8
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
8.71 B Market capitalization

News

Investing Investing
PCVX
2026.03.10
Jefferies reiterates Vaxcyte stock Buy rating on regulatory clarity
Investing Investing
PCVX
2026.02.25
BTIG raises Vaxcyte price target to $89 on vaccine breadth edge
Investing Investing
PCVX
2026.02.25
Leerink raises Vaxcyte stock price target on vaccine pipeline expansion
Seeking Alpha Seeking Alpha
PCVX
2026.02.25
Vaxcyte, Inc. (PCVX) Q4 2025 Earnings Call Transcript
Zacks Zacks
JAZZ ACAD OVV PCVX
2026.02.18
Ovintiv to Report Q4 Earnings: What's in Store for the Stock?
Investing Investing
PCVX
2026.02.02
Vaxcyte closes $632.5 million public offering of common stock
Investing Investing
PCVX
2026.01.30
Vaxcyte prices $550 million public offering of common stock
Seeking Alpha Seeking Alpha
RVMD ABBV FIX FTAI ABVX
2026.01.30
Harbor Small Cap Growth Fund Q4 2025 Portfolio Performance
Investing Investing
PCVX
2026.01.29
Vaxcyte launches $500 million public offering of common stock
Seeking Alpha Seeking Alpha
LABD XBI LABU MRNA RVMD
2026.01.26
LABD: ETF To Benefit From Downturns In The Biotech Industry (NYSEARCA:LABD)
Investing Investing
PCVX
2026.01.23
Cantor Fitzgerald reiterates Overweight rating on Vaxcyte stock
Benzinga Benzinga
PCVX
2026.01.23
Vaxcyte Pushes Next-Gen Pneumococcal Vaccine Into Phase 3 Phase - Vaxcyte (NASDAQ:PCVX)

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
Scan to install from App Store
Scan to install from Google Play
Scan to install from Huawei AppGallery
Scan to install APK
MQL5 Channels
Scan to install from App Store
Scan to install from Google Play
Scan to install from Huawei AppGallery
Scan to install APK
Economic Calendar
Scan to install from App Store
Scan to install from Google Play
Scan to install from Huawei AppGallery
Scan to install APK
Risk Disclosure Terms of Use Help Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd